Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exagen (XGN) Return on Capital Employed (2019 - 2026)

Exagen filings provide 8 years of Return on Capital Employed readings, the most recent being 33.28% for Q1 2026.

  • On a quarterly basis, Return on Capital Employed rose 1584.0% to 33.28% in Q1 2026 year-over-year; TTM through Mar 2026 was 33.28%, a 1584.0% increase, with the full-year FY2025 number at 37.83%, down 128.0% from a year prior.
  • Return on Capital Employed hit 33.28% in Q1 2026 for Exagen, down from 30.41% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 25.42% in Q1 2022 to a low of 61.37% in Q3 2023.
  • Median Return on Capital Employed over the past 5 years was 40.71% (2022), compared with a mean of 42.36%.
  • Biggest five-year swings in Return on Capital Employed: crashed -3458bps in 2023 and later surged 2050bps in 2024.
  • Exagen's Return on Capital Employed stood at 54.64% in 2022, then grew by 11bps to 48.55% in 2023, then increased by 8bps to 44.5% in 2024, then surged by 32bps to 30.41% in 2025, then decreased by -9bps to 33.28% in 2026.
  • The last three reported values for Return on Capital Employed were 33.28% (Q1 2026), 30.41% (Q4 2025), and 26.05% (Q3 2025) per Business Quant data.